Complex API Manufacturer & Supplier in India
Commercial and development-stage complex APIs from PEC Pharma — search the portfolio, review specifications, and request quotes for GMP supply from Gujarat, India.
Complex API Catalogue — Manufacturers & Suppliers
Search or filter commercial and scale-up APIs. Open a product row for specifications and quote requests.
Loading API catalogue…
Complex API Manufacturing Overview
Complex Active Pharmaceutical Ingredients (APIs) demand advanced synthetic expertise, stringent in-process controls and manufacturing environments capable of handling challenging chemistries. PEC Pharma supplies a growing portfolio of commercial Complex APIs alongside a pipeline of products under active development, supporting partners from dossier filing through to commercial supply.
Our commercial API range spans therapeutic categories including alcohol deterrents, topical nasopharyngeal agents, antidepressants, antiepileptics and alpha-blockers for benign prostatic hyperplasia. Products such as Acamprosate calcium, Xylometazoline HCl, Oxymetazoline HCl, Bupropion HCl, Lacosamide and Silodosin are available with documented GMP status and DMF support where indicated.
PEC Pharma is a leading supplier, manufacturer and service provider of pharmaceutical materials, backed by a versatile multipurpose plant, a strong team of qualified professionals and a well-equipped quality-controlled laboratory. Our API business is integrated with CRDMO/CDMO services, enabling seamless progression from development campaigns to commercial manufacturing.
Complex API Applications
- Alcohol dependence management — Acamprosate calcium for maintenance of abstinence programmes
- Nasal decongestant formulations — Xylometazoline HCl and Oxymetazoline HCl for topical nasopharyngeal products
- Depression and smoking cessation support — Bupropion HCl as an antidepressant API
- Epilepsy treatment — Lacosamide for adjunctive antiepileptic therapy
- Benign prostatic hyperplasia — Silodosin as an alpha-blocker API
- Pipeline development — Mirtazapine, Pramipexole, Linezolid, Dimethyl Fumarate, Baclofen and Bisacodyl programmes under development
Why Source Complex APIs from India
- Commercial APIs with GMP status and DMF availability for selected products
- Multi-pharmacopoeia specification support — IH, IP, BP, USP and JP where applicable
- Development pipeline providing future supply options for strategic formulation partners
- Regulatory documentation support for domestic and international market entry
- Integrated CDMO pathway from route development through commercial API supply
- Trusted by more than 500 customers throughout India and globally
How PEC Pharma Manufactures Complex APIs
Complex API manufacture at PEC Pharma is supported by comprehensive process research and development capabilities, including route scouting, stereoselective synthesis, chiral separations, solid form development and process intensification techniques.
Our kilo lab facilities support early CMC campaigns with heating ranges up to 200°C and cooling to -50°C, enabling evaluation of challenging reaction conditions before plant scale-up. Process safety data generation and high-pressure reaction capabilities including hydrogenations and reductive aminations are available for demanding synthetic routes.
Quality is embedded throughout manufacturing via our quality-controlled laboratory. Batch release procedures align with customer specifications and applicable pharmacopoeial standards. PEC Pharma collaborates with manufacturers complying with regulatory support requirements for both domestic and international markets.
Who We Supply Complex APIs To
- Generic pharmaceutical companies filing ANDA, ACTD and country-specific dossiers
- Innovator companies seeking secondary or backup API supply
- CDMO and CMO partners requiring API supply for formulation campaigns
- International distributors in LATAM, CIS, SEA and Africa where PEC Pharma maintains market presence
- Domestic Indian formulation manufacturers sourcing GMP-grade APIs
- Research organisations requiring development quantities from our under-development portfolio
Complex API Specifications & GMP Status
Commercial API specifications are aligned to applicable pharmacopoeial monographs and customer requirements. The product tables below detail therapeutic category, specification grades, regulatory status and DMF availability for each commercial API.
- Pharmacopoeial grades: IH, IP, BP, USP, JP (product-specific)
- Regulatory status: GMP for commercial portfolio
- DMF support: available for selected commercial APIs (see table)
- Certificate of Analysis and batch documentation with every shipment
- Stability data and impurity profile information available on request
Complex API Packaging and Supply
APIs are supplied in primary packaging appropriate to the product's chemical stability profile and customer warehousing requirements. Export-compliant labelling and documentation accompany international shipments to PEC Pharma's established trading regions.
Custom pack sizes and dedicated batch campaigns can be arranged for commercial partners with recurring demand. Discuss your annual volume forecast and packaging preferences during the initial enquiry to receive a tailored supply proposal.
Frequently Asked Questions
Which Complex APIs are commercially available from PEC Pharma?
Our commercial portfolio includes Acamprosate calcium, Xylometazoline HCl, Oxymetazoline HCl, Bupropion HCl, Lacosamide and Silodosin — all with GMP status. DMF support is available for these commercial products.
What APIs are currently under development?
Our development pipeline includes Mirtazapine, Pramipexole Di-HCl, Linezolid, Dimethyl Fumarate, Baclofen and Bisacodyl. Contact us for current development status and anticipated commercial availability.
What pharmacopoeial specifications do you support?
Specification grades vary by product and include IH, IP, BP, USP and JP as listed in our commercial API table. Share your target market and monograph requirements at enquiry stage.
Does PEC Pharma provide DMF and regulatory documentation?
DMF support is confirmed for our commercial API portfolio. PEC Pharma has invested in product development with DMF and dossier regulatory support for international market penetration. Enquire for specific documentation availability per product.
How can I request samples or a commercial quote for APIs?
Contact our team via the enquiry form or email info@pecpharma.in with the API name, required quantity, specification grade and destination market. We will respond with availability, pricing and lead time.